A drug with the SMILES Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc(Cl)c3Cl)s2)n1 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 6.662%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc(Cl)c3Cl)s2)n1
Cc1cc(C)nc(SCC(=O)Nc2ncc(Cc3cccc(Cl)c3Cl)s2)n1
N-[5-[(2,3-dichlorophenyl)methyl]-1,3-thiazol-2-yl]-2-(4,6-dimethylpyrimidin-2-yl)sulfanylacetamide